ERBB2 and cancer: Based on different cancer types, other CTC biomarkers, including estrogen receptor [29], folate receptor [30], human epidermal growth factor receptor-2 (HER2) [31], prostate-specific membrane antigen [32], and survivin [33], have been used in the clinic [25].